Tradestie Institutional Equity Comparison Engine

IMMX vs IBO โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

IBO Overall Edge

IBO Captures Institutional Edge (3โ€“1 Pillars ยท 5โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Impact BioMedical, Inc. (IBO) driven by superior Valuation, Growth & Margin, Momentum & Technical while IMMX counters with relative strength in Options & Structure. Fundamentally, IMMX trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus IBO at N/M Forward P/E and -12621.0% operating margin (+16.7% YoY). In options structure, IMMX sits in BREAKDOWN (17th %ile IV; Dealer Gamma Walls on Pro) against IBO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner IBO
IMMX N/M vs IBO N/M Fwd P/E
Growth & Margin Winner IBO
Op Margin 0.0% vs -12621.0% ยท YoY +0.0% vs +16.7%
Momentum & Technical Winner IBO
1Y +107.2% vs +862.8% ยท 52W Pos 35% vs 67%
Options & Structure Winner IMMX
BREAKDOWN (17th %ile IV) vs UNCLASSIFIED (N/A IV)
IMMX NASDAQ
Immix Biopharma, Inc. Common Stock
Pharmaceutical Preparations
$7.48
-4.59% 1D
Market Cap $657.1M
1M Return -6.27%
1Y Return +107.2%
Forward P/E N/M
Unified AI Score
48.6 / 100 HOLD
Tech 46.0 Fund 55.0 Flow 68.0 Mom 54.0
IBO NYSE American
Impact BioMedical, Inc.
Pharmaceutical Preparations
$4.91
-4.47% 1D
Market Cap $44.4M
1M Return +83.21%
1Y Return +862.75%
Forward P/E N/M
Unified AI Score
36.8 / 100 SELL
Tech 15.0 Fund 32.0 Flow 50.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: IMMX +107.2% IBO +862.75% Spread: +755.55 pp (IBO Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
IMMX TTM Op. Margin: 0.0% IBO TTM Op. Margin: -12621.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on IMMX vs IBO. Trailing 12-month operating profitability (IMMX 0.0% vs IBO -12621.0%) and valuation multiples (IMMX N/M vs IBO N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: IMMX (4) vs IBO (5)
Institutional Metric IMMX IBO Criterion Row Winner
Market Capitalization Scale $657.1M $44.4M Larger Scale IMMX
Trailing P/E Ratio Valuation N/M 0.4x Lower Multiple IBO
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% +16.7% Higher Growth IBO
Operating Margin (TTM) Profitability 0.0% -12621.0% Higher Margin IMMX
Net Profit Margin Profitability 0.0% 4247.4% Higher Margin IBO
Return on Equity (ROE) Capital Efficiency -27.0% 71.2% Higher ROE IBO
52-Week Range Position Momentum 35% ($3โ€“$15) 67% ($0โ€“$7) Stronger Trend IBO
Beta / 30D Volatility Risk Regime 1.80ฮฒ ยท 84% Vol -6.72ฮฒ ยท 120% Vol Lower Realized Risk IMMX
Unified Institutional Score Composite Signal 48.6 / 100 (HOLD) 36.8 / 100 (SELL) Higher Composite IMMX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full IMMX vs IBO Buy Guide
IMMX BREAKDOWN
58d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 17th %ile
IV Regime Compressed (<25th %ile)
Live IMMX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
IBO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live IBO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither IMMX nor IBO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.